THE role of the L-arginine-nitric oxide metabolic pathway was explored for interleukin-2-induced proliferation in the cytotoxic T lymphocyte clone CTLL-2. Specific inhibition of nitric oxide synthase significantly diminished, in a concentration-dependent manner, 3H-thymidine uptake of CTLL-2 cells in response to different concentrations of interleukin 2. Withdrawal of L-arginine from culture medium resulted as potent as the higher inhibition obtained when blocking nitric oxide synthase with L-arginine analogues. Furthermore, intermedial concentrations of Larginine and exogenous nitric oxide donors were found for achieving optimal IL2-induced proliferation of CTLL-2. These findings prompted us to suggest that intra-and/or inter-cellular nitric oxide signalling may contribute to the modulation of the IL2 mitogenic effect upon cytotoxic T lymphocytes.
Introduction
Interleukin-2 (IL2) is among the principal lymphokines used in humans, either alone or in combination with lymphokine-activated killer cells, to treat advanced cancer. Its therapeutic proficiency has been related with the clonal expansion of a broad range of T cell types, but particularly cytotoxic T lymphocytes. 2 However, despite many efforts, most of the signal transduction pathways involved in the proliferation are yet to be elucidated.
Meanwhile, the induction of high nitric oxide (NO) levels has been suggested as being responsible for some of the adverse side effects of IL2 treatment, 3 and further findings have demonstrated the beneficial effect of concomitant administration of L-arginine for improving IL2-induced immune stimulation. 4 Two major nitric Further results (Fig. 2) demonstrated that, in the presence of L-arginine (0.1 mM) and fixed concentration of IL2 (20 U/ml), the specific NOS antagonist LNMMA showed a concentration-dependent inhibitory effect upon CTLL-2 growth. However, in the absence of L-arginine, H-thymidine uptake in all cases remained at a basal plateau resembling that observed when treated with LNMMA (500 bM).
Consistently (Fig. 3) , when different concentrations of L-arginine were assayed for CTLL-2 H-thymidine uptake in the presence of fixed concentration of IL2 (5 U/ml), it was noted that Finally, it was observed that even exogenous administration of NO was able to modulate the proliferation of CTLL-2 cells in response to IL2 (5 U/ml) (Fig. 4) . A well-known NO generator (SNP) was added in a wide range of concentrations and, as with L-arginine, there seems to exist a critical value of concentration of NO (around 20 pmol/ml) for which the proliferation was maximal. Either lower or higher levels of NO may affect the optimal proliferation of CTLL-2 cells.
Discussion
The involvement of NO in the control of the mitogenic activation of T cells was firstly described in models of whole spleen cells proliferation in response to Con A. 1 In that case it was assumed that the NO coming from the co-cultured activated macrophages might be functioning as a suppressor mechanism to downregulate T cells growth. Further studies, however, reported the finding that the NO metabolic pathway was essential for the normal DNA synthesis in purified lymphocytes growing in response to Con A. 11 Such apparent contradiction could be basically explained because of the level and localization of NO generation, but it may be important to also consider the T cell type.
Indeed, different patterns of production and susceptibility to NO for two clones of T helper 
